Shaily Engineering Plastics LtdNSE: SHAILY
Open the Shaily Engineering Plastics Ltd page
Follow Shaily Engineering Plastics LtdFree account. Get a note when Shaily Engineering Plastics Ltd files.
Q1 FY27 results preview · August 03, 2026

Shaily Engineering Plastics Ltd (SHAILY) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto ResearchPublished August 03, 20263 min read
Quick summary

Shaily Engineering Plastics faces a pivotal quarter as it balances rapid expansion in its high-margin healthcare vertical against a cyclical downturn in its legacy home furnishing business. Investors will be looking for signs of margin resilience driven by export-led rupee tailwinds and the ramp-up of new pen-injector capacity.

Quick Details
Results dateAugust 08, 2026
QuarterQ1 FY 2026-2027
Previous quarter revenueRs. 236.8 Cr
Previous quarter PATRs. 40.2 Cr
Previous quarter EBITDA margin29.3%
Net debt (latest quarter)Rs. 148.86 Cr
Market capRs. 14080.99 Cr
CMPRs. 3061.4

Shaily Engineering Plastics Ltd Q1 Results Date and Time

The board meeting is scheduled for August 08, 2026, to consider the audited financial results for Q1 FY27.

What to expect from Shaily Engineering Plastics Ltd's Q1 FY27 results

Shaily is expected to show revenue growth led by its healthcare segment, which reached a quarterly baseline of Rs. 113 Cr in Q4 FY26 and is supported by new pen-injector capacity. The company benefits from a significant export tailwind, as the rupee averaged Rs. 94–95/USD during the quarter compared to the Rs. 87 zone in Q4 FY26, which is expected to support margin expansion.

While the consumer home furnishing segment remains weak—with revenue down 31% YoY in Q4 FY26—the industrial segment is projected to continue its growth trajectory, having posted 41% YoY growth in FY26. Management's ability to maintain EBITDA margins near the 29.3% level seen in Q4 FY26 will be a key focus, especially as the firm navigates rising employee and other expenses which grew 27% YoY in the previous quarter.

Key Things To Watch

Performance vs Guidance Tracking

  • Pen injector production — 36 Mn units target for FY27 — Q1 run-rate tracking
  • Pen capacity addition — 25 Mn units planned for Jul/Aug 2026 — commissioning status
  • Combined pen output — 40-42 Mn units target by year-end — ramp trajectory

Healthcare Segment Growth

  • Q1 healthcare revenue run-rate vs Rs. 113 Cr baseline in Q4 FY26
  • Status of ShailyPen Neo commercial adoption in India and Canada
  • Progress on semaglutide pen capacity installation target of 50 Mn units

Abu Dhabi Facility and Fundraising

  • Update on potential financial support discussions with Abu Dhabi government for Rs. 300-350 Cr project
  • Clarity on quantum, instrument, and use of proceeds for the Rs. 500 Cr enabling resolution passed May 19, 2026

Consumer Segment Pivot

  • Demand trends in European and US home furnishing markets following 31% YoY revenue decline in Q4 FY26
  • Early revenue contribution and pipeline progress for consumer electronics and semiconductor trays

Risks and headwinds to monitor

  • Impact of June 2026 promoter stake sale of 2.27% on governance perception
  • Supply chain resilience and volatility in resin availability flagged as increasing risks

Ask about this

Ask Cofacto a question about this company. Answers cite filings and company data.

Frequently Asked Questions

How did Shaily's healthcare segment perform in the previous quarter?

The healthcare segment reported revenue of Rs. 113 Cr in Q4 FY26, representing a 101% increase compared to Q4 FY25. This segment now contributes approximately 40% of total revenue.

What is the status of Shaily's pen injector capacity?

As of Q4 FY26, the company had a total pen injector capacity of 80 Mn units per year. Management is targeting a combined pen output of 40-42 Mn units by the end of FY27.

What are the company's plans for the Abu Dhabi facility?

The company is investing Rs. 300-350 Cr in an Abu Dhabi facility with a capacity of approximately 75 Mn pen/auto-injectors per year. The facility is expected to be operational by Q4 FY28.

Companies on this page

Related